SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-064707
Filing Date
2019-03-06
Accepted
2019-03-06 07:53:53
Documents
14

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d626180ds3.htm S-3 465033
2 EX-4.16 d626180dex416.htm EX-4.16 26886
3 EX-4.17 d626180dex417.htm EX-4.17 38159
4 EX-4.18 d626180dex418.htm EX-4.18 50821
5 EX-5.1 d626180dex51.htm EX-5.1 8947
6 EX-23.1 d626180dex231.htm EX-23.1 1951
7 EX-99.1 d626180dex991.htm EX-99.1 33205
8 EX-99.2 d626180dex992.htm EX-99.2 10736
9 EX-99.3 d626180dex993.htm EX-99.3 11353
10 EX-99.4 d626180dex994.htm EX-99.4 8632
11 EX-99.6 d626180dex996.htm EX-99.6 24390
12 EX-99.7 d626180dex997.htm EX-99.7 20093
13 EX-99.8 d626180dex998.htm EX-99.8 12491
14 GRAPHIC g626180g0305202043518.jpg GRAPHIC 3284
  Complete submission text file 0001193125-19-064707.txt   718498
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-230085 | Film No.: 19661273
SIC: 2834 Pharmaceutical Preparations